Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates

Should Vanguard S&P Small-Cap 600 ETF (VIOO) Be on Your Investing Radar?

Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress

Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress

Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress

Cytokinetics Taps Sung Lee as Permanent CFO

Cytokinetics Taps Sung Lee as Permanent CFO

Cytokinetics to Announce First Quarter Results on May 8, 2024

Cytokinetics to Announce First Quarter Results on May 8, 2024

Cytokinetics to Announce First Quarter Results on May 8, 2024

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress

EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)

EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)

EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)